Page 42 - MSC & Exosomes in autoimmune
P. 42

Ouyang et al. Stem Cell Research & Therapy  (2018) 9:246                                Page 6 of 12



































              Fig. 3 Intracavernous pressure (ICP) during cavernous nerve (CN) electrostimulation at 4 weeks after surgery. a-d Representative ICP responses for the
              sham group, CNI rats stimulated 4 weeks after IC injection of PBS, MSCs, and MSC-Exos. The colored bar denotes the 50 s CN electrical stimulation. e, f
              The ratios of the total ICP (area under the curve) and maximal ICP to MAP are recorded. Each bar depicts the mean ± standard deviation from n =8
              animals per group. *p < 0.01 compared with the PBS vehicle group


            (MSCs, 0.65 ± 0.03, 0.69 ± 0.03; MSC-Exos, 0.50 ± 0.03,  significant decrease in smooth muscle content in the
            0.60 ± 0.04) compared to the PBS group (p <0.01).  corpus cavernosum of the PBS group compared to the
                                                              sham group (Fig. 5a). The MSCs and MSC-Exos treat-
            Transplantation of MSC-Exos increase penile nNOS  ment groups exhibited partial but significant restoration
            expression and alleviate cell apoptosis           of smooth muscle content after CNI, as shown by west-
            The expression of nNOS in the corpus cavernosum was  ern blot analysis (Fig. 5c, d). The corpus cavernosum
            detected by immunofluorescent staining 4 weeks after  was evaluated for the smooth muscle/collagen ratios on
            injection with MSCs or MSC-Exos. The data revealed  slides stained with Masson’s trichrome (Fig. 5b). In the
            that nNOS expression was significantly higher in the  sham group, the smooth muscle/collagen ratio was
            sham (0.43 ± 0.04), MSCs (0.33 ± 0.04), and MSC-Exos  0.166 ± 0.013. In the penile tissue from rats from that re-
            (0.33 ± 0.10) groups than in the PBS group (0.18 ± 0.03;  ceived MSCs or MSC-Exos, the smooth muscle/collagen
            p < 0.01) (Fig. 4a, b, c). TUNEL assays were applied to  ratio (0.118 ± 0.013 or 0.107 ± 0.013) was almost fully
            assess cell apoptosis in the corpus cavernosum in vivo.  preserved and significantly higher than in the PBS group
            In vivo TUNEL assays confirmed that MSC-Exos effect-  (0.054 ± 0.010) (Fig. 5e,*p < 0.01).
            ively protected cells from apoptosis after CNI. Addition-
            ally,  MSC-Exos  could  alleviate  the  apoptosis  of  CCSMCs identification
            nNOS-positive cells, which also contributed to the re-  Fig. 6 shows primary cells that have migrated out from
            covery of erectile function (Fig. 4a). Western blots were  the corpora tissues after 4–7 days and achieved conflu-
            performed to evaluate the expression of caspase-3 after  ence after 2–3 weeks. It also shows passaged cells grow-
            4 weeks of treatment with MSCs and MSC-Exos. The  ing in a whirlpool-like pattern (Fig. 6a). Over 95% of the
            expression of caspase-3 significantly decreased in the  cultured cells were identified by immunofluorescence
            MSCs (1.52 ± 0.07) and MSC-Exos (1.70 ± 0.06) groups  (IF)-labeling of calponin (Fig. 6b), suggesting highly pure
            compared to the PBS group (2.11 ± 0.15) (Fig. 4d, e).  CCSMCs for the following experiments.

            MSC-Exos treatment improves smooth muscle content  Inhibition of CCSMCs apoptosis using exosomes
            and the ratio of smooth muscle to collagen in the corpus  To assess the anti-apoptotic effects of MSC-Exos on
            cavernosum                                        CCSMCs, we analyzed the viability of exosomes-
            CNI caused corpus cavernosum smooth muscle atrophy,  supplemented cells after H 2 O 2 treatment by flow cytome-
            and computerized histomorphometric analysis showed a  try. CCSMCs were cultured in the absence or presence of
   37   38   39   40   41   42   43   44   45   46   47